profit from every A$100 of sales.
Echo IQ
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
It has no yearly profit to compare the price with.
It holds more cash than debt.
Money in, money out
What Echo IQ sold, what it kept, and what it did with the cash.
Sales went from A$983,183 in 2021 to A$44,500 in 2024, with -A$5.41 million of profit last year.
Echo IQ vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from A$100 of sales | Sales growth a year | Price per A$1 of profit |
|---|---|---|---|
| Echo IQ | No profit yet | ||
Veeva Systems | 54.3× · Expensive | ||
Pro Medicus | 188.0× · Very expensive | ||
Hinge Health | No profit yet | ||
M3 | 30.3× · Expensive |
AI analysis
An AI analyst reads Echo IQ's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of AUD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 1 | 0 | 0 | 0 | |
| 1 | 0 | 0 | 0 | |
| -3 | -6 | -8 | -7 | |
| -3 | -6 | -7 | -6 | |
| -3 | -6 | -8 | -5 | |
| – | -0.02 | -0.02 | -0.01 | |
| 100.0% | 100.0% | 100.0% | 100.0% | |
| -318.9% | -2,489.2% | -7,150.6% | -14,834.4% | |
| -303.1% | -2,259.5% | -7,270.3% | -12,155.4% |
Balance sheet
| In millions of AUD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 11 | 11 | 10 | 8 |
| Cash | 4 | 2 | 3 | 2 |
| Total debt | – | – | – | – |
| Total liabilities | 2 | 4 | 3 | 2 |
| 9 | 8 | 7 | 7 | |
| – | 393 | 448 | 455 | |
| -22.4% | -55.8% | -72.3% | -68.3% | |
| -32.0% | -72.4% | -105.0% | -79.9% |
Cash flow
| In millions of AUD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| – | – | – | – | |
| 0 | 0 | 0 | – | |
| -1 | -3 | -5 | -4 | |
| Dividends paid | – | – | – | – |
| 0 | – | 0 | – | |
| – | – | – | – |
Valuation
- –
- –
- –
- 115.7×
- 8,907.1×
- –
- –
- -1.0%
- -1.4%
- –
Profitability
- 100.0%
- -14,834.4%
- -12,155.4%
- –
- -68.3%
- -54.7%
- –
- –
- –
- –
Growth
- −64.4%
- –
- –
- –
- +13.0%
Financial health
- -0.4×
- –
- –
- –
- 1.03
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/6Passes 0 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Echo IQ
Is Echo IQ a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Echo IQ AI analysis
What does Echo IQ do?
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It is in Health Information Services, based in Sydney, NSW, Australia.
How has Echo IQ stock done over the past year?
Up 328.0% over the past twelve months, to A$0.54. It traded between A$0.12 and A$0.88 and is 38.9% below its high.
Who are Echo IQ's competitors?
The largest listed companies in the same industry are Veeva Systems, Pro Medicus, Hinge Health and M3. The peers table on this page compares their profit, growth and price with Echo IQ's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.



